Open Access4CPS-135 Effectiveness and cost of eculizumab on patients with atypical (shua), urenic and haemolitic syndrome, with enlargement of the frequency of administration
Author(s) -
S Cifuentes,
I Alferez,
Silvia Paz,
P Nieto Guindo,
Elena CuadradoPayán,
F Sierra García
Publication year - 2018
Publication title -
section 4: clinical pharmacy services
Language(s) - English
Resource type - Conference proceedings
DOI - 10.1136/ejhpharm-2018-eahpconf.226
Subject(s) - eculizumab , medicine , creatinine , renal function , haemolysis , thrombotic microangiopathy , retrospective cohort study , urology , gastroenterology , surgery , immunology , antibody , disease , complement system
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom